Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00541008
What this trial is testing

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
UNICANCER 92
Not applicableStudy completedNCT01549925
What this trial is testing

Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand

Who this might be right for
Epithelial Ovarian Cancer
University of Utah 50
Testing effectiveness (Phase 2)WithdrawnNCT03644589
What this trial is testing

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMetastatic Breast Cancer+3 more
University of Washington
Testing effectiveness (Phase 2)Active Not RecruitingNCT06223568
What this trial is testing

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckOropharynxHuman Papillomavirus Viruses+2 more
National Cancer Institute (NCI) 70
Large-scale testing (Phase 3)Looking for participantsNCT06964568
What this trial is testing

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Who this might be right for
Esophageal CarcinomaRadiotherapyImmunotherapy
Fudan University 452
Not applicableApproved For MarketingNCT01160250
What this trial is testing

Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Genentech, Inc.
Very early researchStudy completedNCT03153410
What this trial is testing

Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11
Large-scale testing (Phase 3)Ended earlyNCT00907413
What this trial is testing

Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Weill Medical College of Cornell University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06823479
What this trial is testing

Towards Cure Via Only Ultra-short ICB in CSCC

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Cutaneous Squamous Cell CancerCutaneous Squamous Cell Carcinoma of the Head and Neck+1 more
The Netherlands Cancer Institute 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07343479
What this trial is testing

Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)EGFR Gene MutationsBrain Metastasis
Zhejiang Cancer Hospital 45
Testing effectiveness (Phase 2)Study completedNCT02280317
What this trial is testing

Dose Finding Safety Study of VAL201 in Cancer Patients

Who this might be right for
Stage III Prostate CarcinomaStage IV Prostate Carcinoma
ValiRx Plc 12
Not applicableUnknownNCT05426317
What this trial is testing

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Who this might be right for
MelanomaNon Small Cell Lung CancerRenal Cancer
University Hospital, Clermont-Ferrand 100
Not applicableStudy completedNCT00898417
What this trial is testing

Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT06730750
What this trial is testing

BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 360
Testing effectiveness (Phase 2)Ended earlyNCT01870791
What this trial is testing

Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer

Who this might be right for
Esophageal NeoplasmGastric Neoplasm
University Hospitals, Leicester 21
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Testing effectiveness (Phase 2)WithdrawnNCT01913691
What this trial is testing

Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00085813
What this trial is testing

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
GlaxoSmithKline 70
Very early researchStudy completedNCT03196180
What this trial is testing

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2/3Cervical Squamous Cell Carcinoma In SituCervical Squamous Intraepithelial Neoplasia 2+1 more
National Cancer Institute (NCI) 13
Not applicableEnded earlyNCT01617980
What this trial is testing

Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
German Cancer Research Center 4
Next Page